Current standards and new innovative approaches for treatment of pancreatic cancer
European Journal of Cancer2016Vol. 57, pp. 10–22
Citations Over TimeTop 1% of 2016 papers
Thierry Conroy, Jean‐Baptiste Bachet, Ahmet Ayav, F. Huguet, Aurélien Lambert, Caroline Caramella, Raphaël Maréchal, Jean‐Luc Van Laethem, Michel Ducreux
Related Papers
- → Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells(2014)54 cited
- → Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer(2020)37 cited
- → Comparative effectiveness and resource utilization of <em>nab</em>-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting(2017)33 cited
- → Selenium Induces Pancreatic Cancer Cell Death Alone and in Combination with Gemcitabine(2022)10 cited
- → Biomarkers for Pancreatic Cancer: Is it Ready for Primetime?(2013)2 cited